studi
demonstr
novel
mechan
egcg
revers
neutrophil
elastaseinduc
migrat
cell
found
neutrophil
elastas
directli
trigger
human
adenocarcinoma
cell
migrat
egcg
suppress
elev
tumor
cell
migrat
induc
neutrophil
elastas
observ
egcg
directli
bind
neutrophil
elastas
inhibit
enzymat
activ
base
cdocker
algorithm
md
stimul
gromac
spr
assay
elastas
enzymat
activ
assay
natur
inhibitor
neutrophil
elastas
synthes
tumor
cell
demonstr
express
upregul
egcg
treatment
neutrophil
elastasetr
cell
preliminarili
discov
egcgmedi
induct
express
might
correl
regulatori
effect
egcg
pathway
overal
result
suggest
egcg
amelior
neutrophil
elastaseinduc
migrat
cell
mechan
underli
effect
may
includ
two
process
egcg
directli
bind
neutrophil
elastas
inhibit
enzymat
activ
egcg
enhanc
express
regul
pathway
wide
varieti
cancer
type
lung
cancer
first
second
lead
caus
cancer
death
global
male
femal
respect
surviv
rate
lung
cancer
approxim
despit
therapeut
advanc
diagnosi
treatment
recent
decad
surround
inflamm
tumor
microenviron
exert
mani
tumorpromot
effect
acceler
prolifer
migrat
surviv
malign
cell
promot
angiogenesi
metastasi
improv
understand
molecular
mechan
involv
tumorassoci
inflamm
may
provid
addit
insight
diagnosi
lung
cancer
develop
drug
treatment
egcg
abund
biolog
activ
catechin
well
known
induc
prolifer
apoptosi
mani
type
cancer
lung
cancer
pancreat
cancer
colon
cancer
regard
mechan
action
previou
studi
shown
egcg
exert
antitumor
effect
via
regul
variou
protein
kinas
includ
mitogenactiv
protein
kinas
mapk
famili
member
especi
akt
kinas
egcg
regul
variou
major
signal
pathway
activ
protein
ap
nuclear
b
b
kinas
pathway
howev
molecular
mechan
underli
antitumor
metastat
properti
egcg
specif
context
inflamm
remain
elus
studi
demonstr
addit
contribut
inflamm
progress
lung
cancer
metastasi
novel
molecular
target
egcg
human
neutrophil
elastas
induc
lung
cancer
cell
migrat
neutrophil
compon
tumor
microenviron
recent
thought
play
import
role
tumor
growth
invas
presenc
increas
infiltr
neutrophil
within
tumor
significantli
associ
poorer
clinic
outcom
patient
bronchioloalveolar
carcinoma
neutrophil
elastas
releas
activ
neutrophil
potent
neutrophil
proteas
potenti
substrat
proteas
includ
cytokin
cytokin
receptor
indic
neutrophil
elastas
may
regul
inflammatori
process
recent
report
shown
neutrophil
elastas
directli
induc
uncontrol
tumor
prolifer
lung
adenocarcinoma
mous
model
lung
epitheli
tumor
cell
antitrypsin
aat
serum
glycoprotein
contain
three
potenti
glycosyl
site
acutephas
protein
aat
thought
play
import
role
limit
host
tissu
injuri
trigger
proteas
particularli
human
neutrophil
elastas
hne
clinic
relev
aat
demonstr
individu
inherit
defici
circul
aat
exhibit
increas
suscept
earlyonset
pulmonari
emphysema
liver
pancreat
diseas
neutrophil
elastas
aat
proteas
proteas
inhibitor
counterpart
pair
assum
aatdefici
proteas
antiproteas
balanc
shift
toward
hne
lead
extens
tissu
damag
particularli
caus
emphysema
xu
et
al
demonstr
natur
polyphenol
product
curcumin
inhibit
tumor
prolifer
induc
neutrophil
elastas
via
upregul
aat
lung
cancer
alter
balanc
aat
hne
may
repres
innov
form
lung
cancer
treatment
cell
cultur
treatment
human
lung
adenocarcinoma
cell
line
use
vitro
experi
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
ny
usa
contain
fetal
bovin
serum
fb
uml
penicillin
gml
streptomycin
humidifi
incub
contain
co
air
cell
treat
differ
concentr
neutrophil
elastas
merck
group
darmstadt
germani
andor
egcg
sigmaaldrich
co
st
loui
mo
usa
h
evalu
describ
cell
viabil
assay
cell
viabil
determin
use
cell
titer
aqueou
one
solut
cell
prolifer
assay
mt
assay
promega
madison
wi
usa
cell
seed
plate
densiti
cellswel
allow
adher
h
incub
neutrophil
elastas
andor
egcg
h
l
mt
solut
ad
well
follow
incub
h
result
color
assay
nm
use
micropl
reader
biorad
laboratori
inc
hercul
ca
usa
vitro
wound
heal
assay
wound
heal
assay
perform
previous
describ
liang
et
al
assess
capac
cell
migrat
briefli
cell
seed
plate
cell
reach
confluenc
scratch
appli
use
steril
l
pipett
tip
cell
wash
three
time
phosphat
buffer
salin
pb
initi
wound
examin
olympu
microscop
cell
incub
medium
contain
neutrophil
elastas
andor
egcg
h
wound
photograph
rate
cell
migrat
evalu
base
rate
wound
closur
transwel
migrat
assay
cell
migrat
investig
use
transwel
migrat
assay
cell
suspend
serumfre
dmem
cell
place
upper
chamber
plate
incub
h
follow
fixat
cell
formaldehyd
upper
chamber
gentli
wipe
cotton
swab
remov
nonmigr
cell
migrat
cell
undersid
polycarbon
filter
stain
crystal
violet
count
olympu
microscop
magnif
immunofluoresc
assay
cell
seed
glass
coverslip
environ
contain
co
air
incub
nm
neutrophil
elastas
egcg
addit
h
coverslip
gentli
wash
pb
fix
paraformaldehyd
min
permeabil
pb
contain
triton
min
block
pb
contain
bsa
min
fix
cell
incub
antihuman
zinc
finger
eboxbind
antibodi
cell
signal
technolog
beverli
usa
overnight
humidifi
chamber
cell
wash
incub
correspond
dylight
secondari
antibodi
jackson
immunoresearch
laboratori
west
grove
pa
usa
h
wash
pb
cell
incub
hoechst
gml
sigmaaldrich
min
room
scientif
report
doi
temperatur
sever
wash
immunostain
specimen
observ
laser
scan
confoc
microscop
leica
microsystem
wetzlar
germani
accelri
softwar
inc
san
diego
ca
use
charmm
engin
use
studi
evalu
potenti
molecular
bind
mode
egcg
hne
program
run
use
dell
server
round
rock
tx
cdocker
algorithm
employ
strategi
involv
gener
initi
ligand
orient
activ
site
target
protein
follow
molecular
dynam
md
base
simul
anneal
final
refin
via
energi
minim
crystal
structur
hne
pdb
id
obtain
protein
data
bank
http
www
rcsborgpdb
water
molecul
protein
remov
protein
refin
base
root
mean
squar
deviat
rmsd
egcg
dock
protein
accord
appropri
paramet
begin
egcg
configur
set
differ
orient
randomli
gener
cocryst
ligand
use
posit
control
ligand
bind
site
defin
base
bind
hne
interact
energi
calcul
analyz
interact
ligand
receptor
ligand
dock
activ
site
molecular
dynam
md
simul
perform
use
gromac
program
forc
field
spce
water
condit
select
topolog
process
water
positionrestrain
use
forc
constant
kpr
kj
mol
protein
place
box
least
nm
box
edg
box
defin
cube
genion
process
cl
ad
system
charg
equilibr
md
simul
perform
gromac
program
use
constrain
bond
involv
hydrogen
atom
allow
integr
interv
fs
particl
mesh
ewald
method
use
threshold
nm
employ
account
electrostat
interact
threshold
nm
use
van
der
waal
interact
nonbond
pair
list
updat
everi
ps
coordin
save
everi
ps
accuraci
test
perform
calcul
rmsd
redock
intern
ligand
protein
use
algorithm
bind
free
energi
calcul
trajectori
obtain
molecular
dynam
use
bind
free
energi
calcul
calcul
perform
use
gromac
molecular
mechan
poisson
boltzmann
surfac
area
gmmpbsa
method
implement
gromac
bind
free
energi
proteinligand
complex
given
bind
estim
absolut
free
energi
bind
g
averag
free
energi
complex
receptor
ligand
respect
averag
free
energi
hand
defin
ts
solut
entrop
contribut
system
temperatur
e
mm
molecular
mechan
energi
obtain
bond
nonbond
interact
within
system
repres
follow
equat
g
solv
averag
solvat
free
energi
equal
sum
electrostat
nonpolar
term
repres
g
pb
gb
electrostat
contribut
solvat
free
energi
evalu
finit
differenti
poisson
boltzmann
fdpb
case
pbsa
method
g
non
polar
hydrophob
non
polar
contribut
solvat
free
energi
calcul
sasa
solvent
access
surfac
area
b
constant
gmmpbsa
calcul
molecular
dynam
trajectori
split
snapshot
total
snapshot
extract
frame
obtain
ns
product
run
allow
sampl
flexibl
bind
site
also
obtain
reliabl
free
energi
estim
bind
compar
singl
snapshot
calcul
surfac
plasmon
reson
spr
biosensor
analysi
bind
affin
egcg
hne
vitro
assay
use
sprbase
biacor
instrument
biacor
ab
uppsala
sweden
previous
report
recombin
hne
protein
molecular
mass
kda
pl
pb
puriti
greater
purchas
merck
group
darmstadt
germani
manufactur
indic
materi
could
use
vitro
bind
assay
hne
protein
dissolv
coupl
buffer
gml
mm
sodium
acet
ph
respons
unit
ru
hne
protein
use
ligand
immobil
sensor
chip
use
nethyln
carbodiimid
nhydroxysuccinimid
accord
standard
primari
aminecoupl
procedur
hbsep
mm
hepe
nm
nacl
mm
edta
vv
surfact
ph
use
run
buffer
equilibr
baselin
perform
continu
flow
hbsep
across
chip
surfac
h
biacor
data
collect
use
hbsep
run
buffer
constant
flow
rate
lmin
egcg
serial
dilut
run
buffer
creat
seri
concentr
sampl
inject
channel
flow
rate
lmin
follow
wash
run
buffer
bind
respons
continu
record
ru
frequenc
hz
sensorgram
express
function
time
associ
k
dissoci
k
rate
constant
equilibrium
dissoci
constant
k
k
calcul
concentr
egcg
use
bia
evalu
softwar
version
biacor
langmuir
bind
fit
model
curvefit
effici
evalu
accord
statist
paramet
western
blot
analysi
total
protein
extract
use
ripa
lysi
buffer
equal
amount
protein
subject
sdspage
transfer
polyvinyliden
difluorid
membran
millipor
corp
usa
membran
block
incub
primari
antibodi
vimentin
catenin
aat
insulin
receptor
cell
signal
technolog
beverli
pakt
akt
cell
signal
technolog
cell
signal
technolog
gapdh
sigmaaldrich
overnight
gentl
agit
follow
incub
antirabbit
irdy
secondari
antibodi
h
room
temperatur
two
wash
tbst
perform
secondari
antibodi
label
membran
place
tbst
membran
imag
use
licor
odyssey
scanner
box
manual
place
surround
band
interest
measur
raw
nearinfrar
fluoresc
intens
valu
intralan
background
intens
subtract
use
odyssey
analyt
softwar
licor
lincoln
ne
usa
hne
activ
assay
assess
hne
activ
perform
accord
reaction
termin
via
addit
l
soybean
trypsin
inhibitor
solut
mg
ml
trishcl
buffer
ph
sampl
vortex
absorb
measur
nm
remain
activ
hne
control
calcul
rel
control
absenc
inhibitor
consid
influenc
buffer
substrat
solvent
extract
inhibitori
effect
select
hne
inhibitor
sivelestat
sodium
moll
previous
establish
use
assay
consid
posit
control
evalu
antimetastat
effect
egcg
lung
cancer
neutrophil
elastas
involv
vitro
first
treat
metastat
cell
variou
concentr
neutrophil
elastas
nm
egcg
egcg
neutrophil
elastas
nm
result
mt
prolifer
assay
show
neutrophil
elastas
concentr
least
nm
enhanc
tumor
cell
viabil
among
concentr
test
nm
neutrophil
elastas
display
strongest
effect
fig
thu
select
nm
neutrophil
elastas
intervent
condit
mt
prolifer
assay
result
show
similar
cell
viabil
control
group
group
treat
variou
concentr
egcg
fig
also
show
nonsignific
chang
cell
viabil
group
treat
neutrophil
elastas
nm
group
treat
egcg
neutrophil
elastas
nm
howev
wound
heal
assay
cell
treat
egcg
migrat
much
slower
rate
control
cell
cell
treat
neutrophil
elastas
nm
fig
b
suggest
egcg
display
antimigratori
properti
confirm
result
perform
cell
migrat
assay
use
transwel
chamber
model
shown
fig
group
treat
nm
neutrophil
elastas
display
significantli
migrat
cell
control
group
altern
treatment
either
egcg
exposur
nm
neutrophil
elastas
result
dramat
fewer
migrat
cell
control
treatment
treatment
neutrophil
elastas
nm
alon
result
indic
treatment
egcg
concentr
induc
substanti
antimigratori
effect
without
affect
prolifer
cell
expos
neutrophil
elastas
determin
whether
egcg
regul
hneinduc
emt
process
express
emt
marker
scientif
report
doi
protein
detect
via
western
blot
assay
confoc
microscopi
result
show
vimentin
express
significantli
alter
hne
treatment
howev
specif
inhibitor
hne
sivelestat
sodium
significantli
upregul
express
vimentin
nevertheless
vimentin
protein
level
clearli
downregul
respons
egcg
treatment
presenc
absenc
hne
fig
c
express
catenin
increas
hne
induct
significantli
decreas
treatment
moll
egcg
fig
c
also
detect
express
subcellular
local
recent
studi
suggest
play
role
lung
cancer
invas
metastasi
develop
result
show
express
significantli
increas
treatment
hne
effect
amelior
addit
egcg
fig
addit
subcellular
transloc
cytoplasm
nucleu
detect
treatment
hne
express
nucleu
decreas
treatment
egcg
neutrophil
elastasetr
cell
analyz
bind
pattern
egcg
hne
first
crystal
structur
hne
bound
select
inhibitor
pdb
id
select
interact
energi
egcg
hne
kjmol
similar
interact
energi
kjmol
hne
endogen
inhibitor
activ
bind
site
egcg
hne
pdb
id
defin
ligandbind
site
radiu
anticip
egcg
stabli
dock
ligandbind
domain
lbd
fig
least
residu
lbd
involv
interact
egcg
hne
protein
egcg
potenti
form
hydrogen
bond
moreov
egcg
possess
potenti
aromat
interact
fig
bind
mode
egcg
lbd
hne
provid
detail
structur
insight
interact
compound
hne
protein
furthermor
perform
md
process
use
gromac
softwar
timeaverag
normal
ratio
gyrat
radiu
rmsd
hydrogen
bond
gromac
energi
analyz
reflect
distribut
egcg
molecul
surround
hne
gyrat
radiu
rmsd
ligand
egcg
receptor
hne
trend
toward
stabil
time
progress
fig
b
interact
hbond
number
shown
chang
stabl
rang
time
progress
fig
addit
gromac
energi
fluctuat
time
progress
chang
fig
gmmpbsa
method
calcul
result
show
bind
tabl
verifi
predict
cdockerbas
analysi
egcg
directli
bind
hne
protein
bind
affin
egcg
hne
determin
use
spr
biosensor
technolog
abil
egcg
bind
hne
reflect
ru
valu
directli
record
biacor
instrument
shown
fig
ru
increas
increas
egcg
concentr
indic
egcg
bound
hne
concentrationdepend
manner
associ
k
dissoci
k
equilibrium
dissoci
constant
k
egcg
bind
hne
respect
curvefit
effici
evalu
accord
statist
paramet
spr
assay
valu
calcul
result
indic
egcg
display
specif
bind
affin
hne
fig
first
test
enzym
activ
hne
ad
indic
concentr
hne
substrat
solut
system
result
show
hne
react
substrat
concentrationdepend
manner
fig
establish
steadi
enzymesubstr
reaction
system
test
inhibitori
effect
egcg
indic
concentr
sivelestat
sodium
use
posit
control
evalu
inhibitori
effect
egcg
imag
cell
expos
egcg
sivelestat
sodium
neutrophil
elastas
cell
grown
confluenc
incub
egcg
sivelestat
sodium
andor
nm
neutrophil
elastas
h
cell
label
antihuman
antibodi
dylight
secondari
antibodi
green
hoechst
stain
blue
b
c
protein
level
vimentin
clearli
downregul
respons
egcg
treatment
without
hne
b
express
catenin
increas
hne
induct
significantli
decreas
treatment
moll
egcg
gel
electrophores
use
ident
experiment
condit
result
show
egcg
inhibit
hne
activ
concentrationdepend
manner
egcg
fig
higher
sivelestat
sodium
fig
aat
serin
proteas
inhibitor
serpin
natur
inhibitor
hne
imbal
aat
hne
play
import
role
lung
cancer
progress
base
understand
predominantli
focus
regul
aat
egcg
investig
mechan
egcg
inhibit
hneinduc
cell
prolifer
western
blot
assay
use
assess
whether
aat
protein
level
alter
egcg
cell
coincub
neutrophil
elastas
nm
egcg
enhanc
aat
express
cell
fig
b
neutrophil
elastas
directli
induc
lung
tumor
cell
prolifer
degrad
adapt
protein
subsequ
activ
pathway
tumor
cell
upon
neutrophil
elastas
exposur
protein
level
decreas
phosphoryl
akt
thr
elev
egcg
enhanc
protein
level
fig
c
reduc
phosphoryl
akt
neutrophil
elastasestimul
cell
fig
df
recent
year
egcg
report
inhibit
tumor
prolifer
metastasi
induc
apoptosi
lung
cancer
cell
vitro
vivo
egcg
suppress
proinflammatori
cytokin
chemokin
induc
tolllik
receptor
agonist
prostat
cancer
cell
addit
egcg
suppress
lung
cancer
cell
growth
via
rasgtpaseactiv
protein
domainbind
mani
molecul
involv
antitumor
activ
egcg
includ
jakstat
mapk
wnt
notch
b
cancer
progress
complex
process
pathogen
mechan
remain
somewhat
elus
egcg
consid
natur
multitarget
chemoprevent
agent
thu
possibl
egcg
inhibit
tumor
develop
via
altern
mechan
exclud
purpos
studi
investig
novel
inflammationrel
mechan
egcg
mediat
anticanc
migratori
activ
lung
cancer
recent
studi
suggest
chronic
inflammatori
pulmonari
diseas
emphysema
highli
associ
increas
risk
lung
cancer
independ
smoke
hne
among
potent
proteinas
releas
neutrophil
consid
respons
elastolyt
damag
emphysema
extent
neutrophil
elastas
may
repres
link
emphysema
lung
cancer
recent
report
show
modest
level
neutrophil
elastas
led
uncontrol
prolifer
lung
epitheli
tumor
cell
found
hne
treatment
nm
enhanc
pakt
akt
ratio
pakt
akt
ratio
e
ratio
f
cell
treat
neutrophil
elastas
egcg
sivelestat
sodium
data
present
mean
sem
n
p
p
imag
aat
gapdh
crop
gel
imag
pakt
gapdh
crop
gel
imag
pakt
crop
gel
imag
akt
gapdh
crop
gel
gel
electrophores
use
ident
experiment
condit
scientif
report
doi
model
breast
cancer
therefor
role
hne
gener
consid
major
effector
human
neutrophil
function
particularli
merit
investig
thu
provid
first
evid
proliferationpromot
effect
hne
cell
next
explor
whether
egcg
directli
bind
hne
use
cdocker
algorithm
cdocker
effici
techniqu
use
predict
interact
small
molecul
protein
model
rmsd
analysi
bind
site
defin
base
definit
posit
control
ligand
bind
site
analysi
show
arg
thr
form
hydrogen
bond
hydrogen
phenol
hydroxyl
group
small
molecul
egcg
addit
arg
form
pi
bond
egcg
appli
minim
md
egcg
hne
enabl
us
perform
ligandprotein
interact
analysi
depict
fig
determin
specif
bind
site
directli
transform
cdocker
bind
result
pdb
file
md
prepar
gro
file
analysi
show
interact
egcg
hne
may
involv
instantan
bind
rather
may
long
term
interact
base
result
md
simul
calcul
bind
free
energi
accord
studi
sulea
et
al
verifi
egcg
could
bind
hne
protein
verifi
result
concern
interact
egcg
hne
evalu
bind
affin
egcg
hne
use
spr
biosensor
analysi
result
confirm
comput
model
predict
first
discov
novel
target
multitarget
molecul
egcg
interestingli
inhibitor
hne
sivelestat
sodium
display
lower
affin
hne
egcg
found
low
water
solubl
sivelestat
sodium
led
appear
lipid
solvent
interf
factor
equip
limit
could
resolv
issu
present
studi
confirm
inhibitori
effect
interact
egcg
neutrophil
elastas
activ
enzym
measur
enzymat
activ
neutrophil
elastas
treatment
egcg
sivelestat
sodium
alasbahi
verifi
method
elastas
enzymat
activ
assay
egcg
exert
concentrationdepend
inhibitori
effect
enzymat
activ
neutrophil
elastas
posit
control
sivelestat
sodium
exert
greater
inhibitori
effect
egcg
aat
specif
primari
inhibitor
neutrophil
elastas
assum
aat
might
mediat
inhibitori
effect
egcg
neutrophil
elastaseinduc
cell
migrat
vitro
aat
predominantli
synthes
liver
also
express
extrahepat
tissu
cell
includ
carcinoma
cell
role
aat
cancer
develop
support
laboratori
data
howev
molecular
mechan
underli
role
aat
tumor
cell
migrat
poorli
understood
primari
function
aat
inhibit
neutrophil
elastas
result
indic
protein
level
aat
cell
clearli
increas
treatment
egcg
howev
contribut
aat
tumor
develop
somewhat
controversi
contrast
effect
tumor
growth
aat
shown
correl
poor
prognosi
lung
adenocarcinoma
inhibitori
effect
polymorphonuclear
neutrophil
pmn
prolifer
invas
lung
cancer
hcc
cell
upon
bind
neutrophil
elastas
aat
activ
cleavag
within
reactiv
site
loop
rsl
suicid
action
evid
indic
aat
level
significantli
elev
skin
ne
mice
compar
ne
mice
murin
model
autoimmun
diseas
bullou
pemphigoid
report
defici
circul
aat
highli
associ
lung
inflamm
especi
earli
onset
pulmonari
emphysema
addit
clinic
find
indic
aat
elev
serum
cancer
patient
serum
biomark
diagnosi
lung
cancer
prostat
cancer
previou
studi
show
egcg
inhibit
signal
variou
tumor
cell
previou
data
demonstr
inhibit
neutrophil
elastaseinduc
cell
prolifer
use
curcumin
type
polyphenol
similar
egcg
also
depend
pathway
cell
recent
shown
neutrophil
elastas
releas
activ
neutrophil
within
lung
absorb
adjac
epitheli
tumor
cell
degrad
bind
partner
regulatori
subunit
therebi
induc
hyperact
pathway
lead
uncontrol
tumor
cell
prolifer
result
show
neutrophil
elastaseinduc
decreas
express
significantli
inhibit
egcg
cell
suppress
akt
thought
mediat
antitumor
migrat
properti
egcg
therefor
explor
whether
egcg
treatment
remark
suppress
neutrophil
elastaseinduc
phosphoryl
activ
result
show
express
akt
increas
neutrophil
elastaseinduc
cell
downregul
cotreat
egcg
neutrophil
elastas
moreov
observ
phosphoryl
akt
compar
regul
phosphoryl
phosphoryl
state
significantli
chang
treatment
neutrophil
elastas
result
indic
migrationpromot
effect
neutrophil
elastas
mediat
akt
phosphoryl
might
mediat
regul
posit
control
group
neither
express
significantli
chang
treatment
inhibitor
neutrophil
elastas
sivelestat
sodium
specul
sivelestat
sodium
select
neutrophil
elastas
inhibitor
suppress
metastasi
lung
cancer
contrast
multitarget
natur
product
egcg
via
signal
pathway
taken
togeth
data
suggest
direct
bind
egcg
neutrophil
elastas
stimul
aat
egcg
crucial
inhibit
neutrophil
elastaseinduc
migrat
cell
egcg
howev
molecul
signal
pathway
modul
express
aat
remain
unclear
import
explor
mechan
regul
aat
serpin
highli
relat
lung
inflamm
lung
cancer
addit
role
egcg
neutrophil
elastaseinduc
induct
tumor
metastasi
growth
xenograft
murin
model
lung
cancer
remain
investig
studi
demonstr
egcg
inhibitor
neutrophil
elastas
modul
migrat
nsclc
cell
block
neutrophil
elastaseinduc
migrat
cell
upregul
aat
express
result
provid
novel
inflammationrel
mechan
egcg
prevent
tumor
metastasi
suggest
potenti
egcg
treatment
inflammationrel
diseas
lung
emphysema
fig
